BUDGETS
ACCESS TO YOUR TESTS
MY RESULTS
PROFESSIONAL ACCESS
Description
SAMPLE TYPE: Saliva
1 hour before: Do not eat, chew gum, smoke, or brush your teeth.
Avoid samples containing blood
Rinse mouth with water just before sampling
RESULTS: 20 DAYS
Results delivered from sample reception
The GNT. Estrogens test evaluates genetic variants involved in the synthesis, metabolism, and detoxification of estrogens, as well as their transport, signaling, and systemic effect. It offers a comprehensive view to personalize decisions in gynecological health, hormone therapy, and cancer prevention.
Its objective is to help understand how your genetic profile modulates exposure to estrogenic metabolites, the balance between protective and potentially pro-inflammatory pathways, and its impact on gynecological, cardiovascular, bone, and neurological risk.
- Understand reproductive disorders (e.g., SOMP, endometriosis).
- Select and adjust hormone replacement therapy (HRT) or contraceptives.
- Phase I (hepatic detoxification) → CYP1A1, CYP1A2, CYP1B1, CYP3A4, CYP19A1 (aromatase), CYP17A1.
- Phase II (hepatic detoxification) → COMT, MTHFR, UGT1A1, UGT1A6, SULT1A1.
- Oxidative Stress → GSTM1, GSTT1, SOD2, NQO1.
- Transporters → SHBG, SLCO1B1, SLCO2B1.
- Receptors → ESR1, PGR.
- Basic coagulation → F2, F5.
For more information, contact the Teletest administration department at 932 12 33 45 or through the following form
